Advanced imaging for diabetic retinopathy

糖尿病视网膜病变的先进成像

基本信息

项目摘要

DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a major cause of visual loss in diabetic individuals that presents a significant diagnostic challenge. Advances in preventing vision loss in these individuals are hindered by limited understanding of mechanisms underlying DR and the altered relationships between the retinal neural tissue and retinal vasculature. Therefore, an objective test for the early diagnosis and evaluation of DR treatment is certainly needed in order to identify the individuals at great risk for vision-threatening problems. Our goal is to prevent visual loss in diabetic patients with an advanced imaging technique, Doppler Fourier Domain Optical Coherence Tomography (Doppler FD-OCT) that can facilitate a better understanding of the underlying sight- threatening complications of DR and the altered relationships between the neural retina and blood vessels. Our objective is to test the hypothesis that retinal structure alteration precedes disturbances in retinal hemodynamics and visual function deficit in DR. We will accomplish the following aims: Aim 1: Test the hypothesis the diagnostic power of the combination of advanced Doppler FD-OCT imaging and novel quantitative functional-anatomical measures can provide an objective methodology for non-invasive and in vivo quantification of retinal hemodynamics and structure morphology in normal healthy subjects and diabetic patients with and without DR. Aim 2: Test the hypothesis that retinal structure alteration precedes disturbances in retinal hemodynamics and visual function deficit in DR. Our hypothesis predicts that retinal structure alteration precedes disturbance of retinal hemodynamics, and at each stage of progressive DR the magnitude of structure deterioration will be larger than the magnitude of hemodynamic disturbance and visual function deficit. We will define the ratio of dysfunction to retinal structure alterations and hemodynamic disturbances at different stages of retinopathy by comparing anatomical variables, hemodynamic parameters and visual function measures. Our results will provide quantitative information about retinal blood flow in diabetic patients with and without retinopathy, and will improve the early diagnosis and treatment of DR. Our expected outcome will be to facilitate a ratio of visual dysfunction to retinal structure alterations and hemodynamic disturbances at different stages of retinopathy. We will characterize the retinal structure and hemodynamic parameters and relate the findings to systemic measures of control and complications in defined stratified groups of diabetic patients with varying levels of DR. Our impact will influence clinical practice by providing a means of identifying better clinical endpoints for DR clinical trials that are more sensitive to early disease progression than visual acuity and define the exact role of the blood circulation abnormalities in the DR progression. PUBLIC HEALTH RELEVANCE: Diabetic retinopathy is a major public health concern, and efforts should be focused on its prevention. An understanding of the mechanism of diabetic retinopathy is important for elucidating its pathogenesis for early detection and identification of potential future therapies. It will be helpful for healthcare providers and the public to be able to estimate a person's risk of diabetic retinopathy.
描述(申请人提供):糖尿病视网膜病变(DR)是糖尿病患者视力丧失的主要原因,对诊断提出了重大挑战。这些个体在预防视力丧失方面的进展受到对DR潜在机制的有限了解以及视网膜神经组织和视网膜血管系统之间关系变化的阻碍。因此,对糖尿病视网膜病变的早期诊断和治疗评估进行客观测试,以确定存在严重视力威胁问题风险的个体,是非常必要的。我们的目标是通过一种先进的成像技术--多普勒傅立叶域光学相干断层扫描(多普勒FD-OCT)预防糖尿病患者的视力损失,该成像技术可以帮助更好地了解潜在的威胁视力的DR并发症以及神经视网膜和血管之间的变化关系。我们的目标是验证视网膜结构改变先于视网膜血流动力学紊乱和视功能障碍的假说。我们将完成以下目标:目的1:检验这一假说先进的多普勒FD-OCT成像和新的定量功能解剖测量方法的结合可以为无创和活体量化正常人和糖尿病患者的视网膜血流动力学和结构形态提供一种客观的方法学。目的2:检验视网膜结构改变先于视网膜血流动力学障碍和视功能障碍的假说。我们的假设预测视网膜结构改变先于视网膜血流动力学紊乱,在进展性糖尿病视网膜病变的各个阶段,结构恶化的程度均大于血流动力学障碍和视功能损害的程度。我们将通过比较解剖变量、血流动力学参数和视功能指标来确定视网膜病变不同阶段的功能障碍与视网膜结构改变和血流动力学障碍的比率。我们的研究结果将提供有无视网膜病变的糖尿病患者的视网膜血流的定量信息,并将改善DR的早期诊断和治疗。我们的预期结果将是促进视网膜病变不同阶段的视觉功能障碍与视网膜结构变化和血流动力学障碍的比率。我们将确定视网膜结构和血流动力学参数的特征,并将研究结果与不同DR水平的已定义分层糖尿病患者的系统控制措施和并发症相关联。我们的影响将通过为DR临床试验提供一种更好的临床终点来影响临床实践,这些临床试验对早期疾病进展比视力更敏感,并确定血液循环异常在DR进展中的确切作用。 公共卫生相关性:糖尿病视网膜病变是一个主要的公共卫生问题,应将重点放在预防上。了解糖尿病视网膜病变的发病机制对于阐明其发病机制、早期发现和确定未来可能的治疗方法具有重要意义。这将有助于医疗保健提供者和公众能够估计一个人患糖尿病视网膜病变的风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Delia Cabrera DeBuc其他文献

Delia Cabrera DeBuc的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Delia Cabrera DeBuc', 18)}}的其他基金

An AI-assisted screening platform within a multivariate framework for biomarkers of mild cognitive impairment due to Alzheimer's disease
多变量框架内的人工智能辅助筛查平台,用于阿尔茨海默病引起的轻度认知障碍的生物标志物
  • 批准号:
    10571773
  • 财政年份:
    2021
  • 资助金额:
    $ 41.23万
  • 项目类别:
An AI-assisted screening platform within a multivariate framework for biomarkers of mild cognitive impairment due to Alzheimer's disease
多变量框架内的人工智能辅助筛查平台,用于阿尔茨海默病引起的轻度认知障碍的生物标志物
  • 批准号:
    10552520
  • 财政年份:
    2021
  • 资助金额:
    $ 41.23万
  • 项目类别:
An AI-assisted screening platform within a multivariate framework for biomarkers of mild cognitive impairment due to Alzheimer's disease
多变量框架内的人工智能辅助筛查平台,用于阿尔茨海默病引起的轻度认知障碍的生物标志物
  • 批准号:
    10252098
  • 财政年份:
    2021
  • 资助金额:
    $ 41.23万
  • 项目类别:
Advanced imaging for diabetic retinopathy
糖尿病视网膜病变的先进成像
  • 批准号:
    8828207
  • 财政年份:
    2011
  • 资助金额:
    $ 41.23万
  • 项目类别:
Advanced imaging for diabetic retinopathy
糖尿病视网膜病变的先进成像
  • 批准号:
    8607953
  • 财政年份:
    2011
  • 资助金额:
    $ 41.23万
  • 项目类别:
Advanced imaging for diabetic retinopathy
糖尿病视网膜病变的先进成像
  • 批准号:
    8444056
  • 财政年份:
    2011
  • 资助金额:
    $ 41.23万
  • 项目类别:
Advanced imaging for diabetic retinopathy
糖尿病视网膜病变的先进成像
  • 批准号:
    8415887
  • 财政年份:
    2011
  • 资助金额:
    $ 41.23万
  • 项目类别:
Advanced imaging for diabetic retinopathy
糖尿病视网膜病变的先进成像
  • 批准号:
    8212080
  • 财政年份:
    2011
  • 资助金额:
    $ 41.23万
  • 项目类别:

相似海外基金

Variability of Brain Reorganization in Blindness
失明时大脑重组的变异性
  • 批准号:
    10562129
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
Beyond the Visual: Blindness and Expanded Sculpture
超越视觉:失明与扩展的雕塑
  • 批准号:
    AH/Y005856/1
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
    Research Grant
Innovative therapeutic strategies to support elimination of river blindness
支持消除河盲症的创新治疗策略
  • 批准号:
    10754120
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
Anatomical, neural, and computational constraints on sensory cross-modal plasticity following early blindness
早期失明后感觉跨模态可塑性的解剖学、神经学和计算限制
  • 批准号:
    10570400
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
Follow on to: Preventing avoidable blindness through smart home-monitoring of vision
继续:通过智能家居视力监测预防可避免的失明
  • 批准号:
    ES/Y001346/1
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
    Research Grant
Establishment of preventive methods for blindness due to pathologic myopia by targeting CCDC102B
以CCDC102B为靶点建立病理性近视致盲预防方法
  • 批准号:
    23K09009
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of neural compensation in the retina and dysfunction in congenital stationary night blindness
先天性静止性夜盲症视网膜神经代偿机制及功能障碍
  • 批准号:
    10678730
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
NSF Convergence Accelerator Track H: Phase II Smart Wearables for Expanding Workplace Access for People with Blindness and Low Vision
NSF 融合加速器轨道 H:第二阶段智能可穿戴设备,扩大失明和低视力人士的工作场所使用范围
  • 批准号:
    2345139
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
    Cooperative Agreement
3D bioprinting of regenerative, corneal cell-laden inks to treat corneal blindness
3D 生物打印充满角膜细胞的再生墨水来治疗角膜失明
  • 批准号:
    10606474
  • 财政年份:
    2023
  • 资助金额:
    $ 41.23万
  • 项目类别:
From 'plant blindness' to 'bug blindness': disseminating an evidence-based pedagogy for plants and refining methodologies in attitudinal research
从“植物盲”到“虫盲”:传播植物循证教育学并完善态度研究方法
  • 批准号:
    ES/X007324/1
  • 财政年份:
    2022
  • 资助金额:
    $ 41.23万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了